Get started

BiondVax Pharmaceuticals Ltd

At close
No trades
See on super-charts
Overview
News Ideas Financials Technicals Forecast

BVXV chart

Key stats

Market capitalization
17.727KUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−5.88USD

About BiondVax Pharmaceuticals Ltd

ISIN
US09073Q2049
Sector
Health Technology
Industry
Pharmaceuticals: Other
Website
biondvax.com
CEO
Amir Reichman
Headquarters
Jerusalem
Employees
15
Founded
2003

BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.

Ideas

BVXV innovative COVID-19 nanosized antibodiesBiondVax has signed definitive agreements with the Max Planck Society and the University Medical Center Göttingen to enter into a strategic collaboration for the development and commercialization of innovative COVID-19 nanosized antibodies (NanoAbs). NanoAbs exhibited in-vitro neutralization of a
Long
Risk Vs Rewards BVXV Long time PLAYHi and welcome to my speculation idea .. After running scanner I have came a cross this ticker many times but today I did some research and I'm willing to do small l investment on this. Its pure speculation but I feel good about it . This ticker might take long long time to get where
Long
1
BVXV, hits a 3-month low of $5.2, shedding -87.16%In comparison, the broader Pharmaceuticals: Major Industry returned -23% over the same period. Tickeron A.I.dvisor analyzed 186 other stocks in the Pharmaceuticals: Major Industry over the last three months, and found that 30 of them (16.36%) exhibited an Uptrend while 156 of them (83.64%) exhibited
Long

See all ideas 

News flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
‪0‬
Revenue
‪0‬

Gain new superpowers

Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn more